RecallRadar

FDA Drug recall D-0391-2026

Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by:…

On 2026-03-25 the FDA classified a Class III recall of Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by:… by Annora Pharma Private, citing presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0391-2026
ClassificationClass III
Statusongoing
Initiated2026-02-03
Published2026-03-25
Last updated2026-09-13 11:52 UTC
CompanyAnnora Pharma Private
DistributionTN

Product

Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Pharma Pvt. LTd., Sengareddy - 502313, Telengana, India, NDC 72603-479-01.

Reason

Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg

Identifiers

ndc72603-479-01
ndc72603-480-01
code_infoLot #: A252487, Exp 05/31/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0391-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.